References
Original article
Mathur, M. et al. A Phase 2 trial of sibeprenlimab in patients with IgA nephropathy. N. Eng. J. Med. https://doi.org/10.1056/NEJMoa2305635 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, M. Targeting APRIL to slow progression of IgA nephropathy. Nat Rev Nephrol 20, 6 (2024). https://doi.org/10.1038/s41581-023-00794-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-023-00794-x
- Springer Nature Limited